This is very promising, although the data set is very small. At least, it is worth continuing testing, given that neutralizing antibodies are generated.
- They've been around almost 10 years but have never had a drug make it to Phase 3 let alone gain FDA approval.
- No company has ever created an mRNA virus for use in humans that was FDA approved.
- Long history of secrecy and not publishing peer-reviewed results.
- They started work on this vaccine in January, had it ready to start Phase 1 in March, and now are releasing (partial, non-peer reviewed) results showing damn near a 100% effectiveness in creating neutralizing antibodies with minimal mild side effects.
- Combine all that with the timing of their financing and relationship between their board and the Trump admin.
